219 related articles for article (PubMed ID: 22624766)
21. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
22. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Hay KD; Bishop PA
N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
[TBL] [Abstract][Full Text] [Related]
23. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Grasko JM; Herrmann RP; Vasikaran SD
J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
[No Abstract] [Full Text] [Related]
24. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
27. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
28. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
[No Abstract] [Full Text] [Related]
29. Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Mast G; Otto S; Mücke T; Schreyer C; Bissinger O; Kolk A; Wolff KD; Ehrenfeld M; Stürzenbaum SR; Pautke C
J Craniomaxillofac Surg; 2012 Oct; 40(7):568-71. PubMed ID: 22118926
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
Kos M; Kuebler JF; Luczak K; Engelke W
J Craniomaxillofac Surg; 2010 Jun; 38(4):255-9. PubMed ID: 19592261
[TBL] [Abstract][Full Text] [Related]
31. Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.
Coviello V; Peluso F; Dehkhargani SZ; Verdugo F; Raffaelli L; Manicone PF; D' Addona A
J Biol Regul Homeost Agents; 2012; 26(1):151-5. PubMed ID: 22475108
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
[TBL] [Abstract][Full Text] [Related]
33. Auto-fluorescence of the bone and its use for delineation of bone necrosis.
Ristow O; Pautke C
Int J Oral Maxillofac Surg; 2014 Nov; 43(11):1391-3. PubMed ID: 25128260
[TBL] [Abstract][Full Text] [Related]
34. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
Marx RE; Cillo JE; Ulloa JJ
J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: similarities with phossy jaw.
Campisi G; Compilato D; Angelo I; Lo Muzio L; Colella G
Indian J Dent Res; 2012; 23(5):683-5. PubMed ID: 23422621
[TBL] [Abstract][Full Text] [Related]
36. Development of a rat model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Marino KL; Zakhary I; Abdelsayed RA; Carter JA; O'Neill JC; Khashaba RM; Elsalanty M; Stevens MR; Borke JL
J Oral Implantol; 2012 Sep; 38 Spec No():511-8. PubMed ID: 21905888
[TBL] [Abstract][Full Text] [Related]
37. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
38. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
Mortensen M; Lawson W; Montazem A
Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
[TBL] [Abstract][Full Text] [Related]
39. Osteonecrosis of the jaws and bisphosphonates. Report of three cases.
Pastor-Zuazaga D; Garatea-Crelgo J; Martino-Gorbea R; Etayo-Pérez A; Sebastián-López C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E76-9. PubMed ID: 16388300
[TBL] [Abstract][Full Text] [Related]
40. Conservative management of medication-related osteonecrosis of the maxilla with an obturator prosthesis.
Troeltzsch M; Probst F; Troeltzsch M; Ehrenfeld M; Otto S
J Prosthet Dent; 2015 Mar; 113(3):236-41. PubMed ID: 25444286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]